Cresset Asset Management’s Moderna MRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $582K | Buy |
21,086
+2,666
| +14% | +$73.6K | ﹤0.01% | 994 |
|
|
2025
Q1 | $522K | Buy |
+18,420
| New | +$522K | ﹤0.01% | 1034 |
|
|
2024
Q4 | – | Sell |
-31,205
| Closed | -$2.09M | – | 1923 |
|
|
2024
Q3 | $2.09M | Buy |
31,205
+6,571
| +27% | +$439K | 0.01% | 773 |
|
|
2024
Q2 | $2.93M | Buy |
24,634
+2,478
| +11% | +$294K | 0.01% | 554 |
|
|
2024
Q1 | $2.36M | Buy |
22,156
+6,127
| +38% | +$653K | 0.01% | 565 |
|
|
2023
Q4 | $1.59M | Buy |
16,029
+1,027
| +7% | +$102K | 0.01% | 675 |
|
|
2023
Q3 | $1.55M | Sell |
15,002
-1,011
| -6% | -$104K | 0.01% | 631 |
|
|
2023
Q2 | $1.95M | Buy |
+16,013
| New | +$1.95M | ﹤0.01% | 531 |
|
|
2022
Q2 | – | Sell |
-2,118
| Closed | -$365K | – | 1039 |
|
|
2022
Q1 | $365K | Sell |
2,118
-408
| -16% | -$70.3K | ﹤0.01% | 709 |
|
|
2021
Q4 | $642K | Sell |
2,526
-43
| -2% | -$10.9K | 0.01% | 609 |
|
|
2021
Q3 | $989K | Buy |
+2,569
| New | +$989K | 0.01% | 394 |
|